Skip to main content
. 2019 Oct 23;8(11):1758. doi: 10.3390/jcm8111758

Table 2.

Predicting factors for concordant EGFR mutation detected in liquid/tissue biopsy.

Variables Univariate Analysis Multivariable Analysis—Maximal Model Multivariable Analysis—Reduced Model
OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Male (vs. female) 1.49 (0.42–5.19) 0.5354 1.83 (0.28–12.11) 0.5296
Age ≥65 (vs. <65) 0.96 (0.30–3.05) 0.9448 1.46 (0.19–11.27) 0.7161
ECOG ≥2 (vs. ≤1) 0.25 (0.02–2.97) 0.2722 0.06 (0.00–21.15) 0.3423
T3–4 (vs. T1–2) 2.25 (0.60–8.42) 0.2286 10.48 (0.87–126.59) 0.0645 5.45 (0.98–30.24) 0.0527
N1–3 (vs. N0) 7.07 (1.93–25.85) 0.0031 10.06 (1.28–78.79) 0.0280 8.71 (1.88–40.35) 0.0057
Brain metastasis (with vs. without) 9.71 (1.15–82.39) 0.0371 5.87 (0.36–96.65) 0.2153
Lung metastasis (with vs. without) 0.71 (0.22–2.30) 0.5728 0.31 (0.04–2.47) 0.2666
Bone metastasis (with vs. without) 7.69 (1.85–31.91) 0.0049 8.15 (0.99–66.95) 0.0510 9.65 (1.72–54.05) 0.0099
Pleural metastasis (with vs. without) 1.20 (0.38–3.79) 0.7561 0.49 (0.06–3.80) 0.4954
Liver metastasis (with vs. without) 3.04 (0.33–28.23) 0.3291 5.26 (0.29–96.02) 0.2630
Pericardial metastasis (with vs. without) 4.57 (0.52–40.56) 0.1721 0.99 (0.04–22.00) 0.9943
Adrenal metastasis (with vs. without) 3.04 (0.33–28.23) 0.3291 3.85 (0.19–78.24) 0.3808
Metastasis to other sites (with vs. without)

Abbreviations: EGFR = epidermal growth factor receptor; OR = odds ratio; CI = confidence interval; ECOG = Eastern Cooperative Oncology Group. Reduced multivariable models were developed with backward variable selection method, keeping only variables with p value less than 0.1, from the maximal model. Because all cases with metastasis to other sites were in the concordant group, odds ratio could not be estimated. This variable was therefore not included in the models.